Flowerkist Incorporated has announced its partnership with Dabur Research Foundation (DRF) on the development of a range of hemp-based CBD infused topical products.
The products reportedly utilize DRF's patent-pending Rapid Penetration Technology.
Under the terms of the agreement, DRF will provide formulation development as well as verification of safety and efficacy. Flowerkist will be responsible for the global distribution and marketing of the products.
Dr. Manu Jaggi, COO of DRF, stated, "For the last several years, we have been investigating the biology of cannabinoids including CBD and working on various technologies to overcome challenges in delivery of efficacious products in this space. What attracted our attention was Flowerkist’s superior vision on how to best capitalize on this emerging global category."
